Continuous treatment reduces malaria risk in young children

Researchers at the University of California, San Francisco, published data showing that Ugandan children 6 to 24 months of age at risk of contracting malaria were 58% less likely to develop malaria when receiving monthly dihydroartemisinin/piperaquine (DP) treatment compared to a control group that did not receive any drug treatment, which is standard medical practice in Uganda. ...